Rafael Burgos

Dr. Rafael Burgos

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
CMCarolina Manosalva
Carolina Manosalva
JQJohn Quiroga
John Quiroga
AHAlejandra I. Hidalgo
Alejandra I. Hidalgo
PAPablo Alarcón
Pablo Alarcón
NANicolás Ansoleaga
Nicolás Ansoleaga
RBRafael Burgos
Rafael Burgos
During an inflammatory process, shift in the cellular metabolism associated with an increase in extracellular acidification are well-known features. This pH drop in the inflamed tissue is largely attributed to the presence of lactate by an increase in glycolysis. In recent years, evidence has accumulated describing the role of lactate in inflammatory processes; however, there are differences as to whether lactate can currently be considered a pro- or anti-inflammatory mediator. Herein, we review these recent advances on the pleiotropic effects of lactate on the inflammatory process. Taken together, the evidence suggests that lactate could exert differential effects depending on the metabolic status, cell type in which the effects of lactate are studied, and the pathological process analyzed. Additionally, various targets, including post-translational modifications, G-protein coupled receptor and transcription factor activation such as NF-κB and HIF-1, allow lactate to modulate signaling pathways that control the expression of cytokines, chemokines, adhesion molecules, and several enzymes associated with immune response and metabolism. Altogether, this would explain its varied effects on inflammatory processes beyond its well-known role as a waste product of metabolism.

8 April 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
MMMaria Daniella Carretta Muñoz
Maria Daniella Carretta Muñoz
JQJohn Quiroga
John Quiroga
RLRodrigo López
Rodrigo López
MHMaría Angélica Hidalgo
María Angélica Hidalgo
RBRafael Burgos
Rafael Burgos
Short-chain fatty acids (SCFAs) are the main metabolites produced by the bacterial fermentation of dietary fiber, and they play a critical role in the maintenance of intestinal health. SCFAs are also essential for modulating different processes, and they have anti-inflammatory properties and immunomodulatory effects. As the inflammatory process predisposes the development of cancer and promotes all stages of tumorigenesis, an antitumor effect has also been associated with SCFAs. This is strongly supported by epidemiological studies showing that a diet rich in fiber is linked to a reduced risk of colon cancer and has significant clinical benefits in patients with inflammatory bowel disease (IBD). SCFAs may signal through the metabolite-sensing G protein-coupled receptors free fatty acid receptor 3 [FFAR3 or G protein-coupled receptor 41 (GPR41)], FFAR2 (GPR43), and GPR109A (also known as hydroxycarboxylic acid receptor 2 or HCAR2) expressed in the gut epithelium and immune cells. This review summarizes the existing knowledge regarding the SCFA-mediated suppression of inflammation and carcinogenesis in IBD and colon cancer.

22 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RBRafael Burgos
Rafael Burgos
PAPablo Alarcon
Pablo Alarcon
JQJohn Andrés Quiroga
John Andrés Quiroga
MCManosalva Carolina
Manosalva Carolina
JHJuan Hancke
Juan Hancke
Andrographolide is a labdane diterpene and the main active ingredient isolated from the herb Andrographis paniculata. Andrographolide possesses diverse biological effects including anti-inflammatory, antioxidant, and antineoplastic properties. Clinical studies have demonstrated that andrographolide could be useful in therapy for a wide range of diseases such as osteoarthritis, upper respiratory diseases, and multiple sclerosis. Several targets are described for andrographolide, including the interference of transcription factors NF-κB, AP-1, and HIF-1 and signaling pathways such as PI3K/Akt, MAPK, and JAK/STAT. In addition, an increase in the Nrf2 (nuclear factor erythroid 2–related factor 2) signaling pathway also supports its antioxidant and anti-inflammatory properties. However, this scenario could be more complex since recent evidence suggests that andrographolide targets can modulate glucose metabolism. The metabolic effect of andrographolide might be the key to explaining the diverse therapeutic effects described in preclinical and clinical studies. This review discusses some of the most recent evidence about the anti-inflammatory and metabolic effects of andrographolide.

1 March 2005 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
MHMaría A Hidalgo
María A Hidalgo
ARAlex Romero
Alex Romero
Jaime Figueroa V.Jaime Figueroa V.
Jaime Figueroa V.
PCPatricia Cortés
Patricia Cortés
ICIlona I Concha
Ilona I Concha
RBRafael Burgos
Rafael Burgos

29 April 2009 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
RBRafael Burgos
Rafael Burgos
JHJ. L. Hancke
J. L. Hancke
JBJ. C. Bertoglio
J. C. Bertoglio
VAV. Aguirre
V. Aguirre
SAS. Arriagada
S. Arriagada
DCD. D. Cáceres
D. D. Cáceres

5 March 2015 in Veterinary Research
Verified
Journal Article
Open access
PDF file
Tamara Munoz-CaroTamara Munoz-Caro
Tamara Munoz-Caro
SHSandra-Jaqueline Mena Huertas
Sandra-Jaqueline Mena Huertas
ICIvan Conejeros
Ivan Conejeros
PAPablo Alarcon
Pablo Alarcon
MHMaría Angélica Hidalgo
María Angélica Hidalgo
ATAnja Taubert
Anja Taubert
Eimeria bovis is an important coccidian parasite that causes high economic losses in the cattle industry. We recently showed that polymorphonuclear neutrophils (PMN) react upon E. bovis sporozoite exposure by neutrophil extracellular trap (NET) formation. We focused here on the molecular mechanisms that are involved in this process. The sporozoite encounter led to an enhanced surface expression of neutrophil CD11b suggesting a potential role of this receptor in E. bovis-mediated NETosis. Antibody-mediated blockage of CD11b confirmed this assumption and led to a significantly decreased sporozoite-triggered NET. In addition, E. bovis-induced NETosis was found to be Ca2+-dependent since the inhibition of store-operated calcium entry (SOCE) significantly diminished NET. Furthermore, NADPH oxidase, neutrophil elastase (NE) and myeloperoxidase (MPO) were confirmed as key molecules in sporozoite-triggered NETosis, as inhibition thereof blocked parasite-triggered NET. PMN degranulation analyses revealed a significant release of matrix metalloprotease-9 containing granules upon sporozoite exposure. We further show a significantly enhanced phosphorylation of ERK1/2 and p38 MAPK in sporozoite-exposed PMN indicating a key role of this signaling pathway in E. bovis-mediated NETosis. Accordingly, ERK 1/2 and p38 MAPK inhibition led to a significant decrease in NET formation. Finally, we demonstrate that sporozoite-induced NETosis is neither a stage-, species-, nor host-specific process.